PharmaEssentia Corporation (6446.TW)

TWD 573.0

(1.24%)

Net Debt Summary of PharmaEssentia Corporation

  • PharmaEssentia Corporation's latest annual net debt in 2023 was -18.46 Billion TWD , down -111.4% from previous year.
  • PharmaEssentia Corporation's latest quarterly net debt in 2024 Q2 was -18.98 Billion TWD , down -5.12% from previous quarter.
  • PharmaEssentia Corporation reported annual net debt of -8.73 Billion TWD in 2022, down -199.41% from previous year.
  • PharmaEssentia Corporation reported annual net debt of -2.91 Billion TWD in 2021, down -14.25% from previous year.
  • PharmaEssentia Corporation reported quarterly net debt of -18.98 Billion TWD for 2024 Q2, down -5.12% from previous quarter.
  • PharmaEssentia Corporation reported quarterly net debt of -19.74 Billion TWD for 2023 Q3, up 7.23% from previous quarter.

Annual Net Debt Chart of PharmaEssentia Corporation (2023 - 2019)

Historical Annual Net Debt of PharmaEssentia Corporation (2023 - 2019)

Year Net Debt Net Debt Growth
2023 -18.46 Billion TWD -111.4%
2022 -8.73 Billion TWD -199.41%
2021 -2.91 Billion TWD -14.25%
2020 -2.55 Billion TWD -148.8%
2019 -1.02 Billion TWD 0.0%

Peer Net Debt Comparison of PharmaEssentia Corporation

Name Net Debt Net Debt Difference
Grape King Bio Ltd -4.62 Billion TWD -299.193%
Standard Chem & Pharm CO., LTD. -954.74 Million TWD -1834.113%
Maywufa Company Ltd. 264.18 Million TWD 7089.726%
ScinoPharm Taiwan, Ltd. -3.32 Billion TWD -456.128%
Lotus Pharmaceutical Co., Ltd. 9.81 Billion TWD 288.16%
LIWANLI Innovation Co., Ltd. -244.02 Million TWD -7467.24%
YungShin Global Holding Corporation -247.5 Million TWD -7360.902%
PhytoHealth Corporation -34.64 Million TWD -53206.218%
SCI Pharmtech, Inc. 100.41 Million TWD 18489.124%
Formosa Laboratories, Inc. 2.53 Billion TWD 827.461%
Bora Pharmaceuticals Co., LTD. 1.95 Billion TWD 1043.792%